NIH HMO Collaboratory Coordinating Center Limited Competition (U54) | Apply Online

Opportunity Summary:

The NIH HMO Collaboratory Coordinating Center Limited Competition (U54) funding opportunity (RFA-RM-11-003) is a NIH Common Fund initiative designed to build a central Coordinating Center that helps multiple health care organizations work together as a distributed research network. The award mechanism is a cooperative agreement (U54), which generally means NIH expects substantial involvement in the project through collaboration, coordination, and ongoing stewardship rather than a purely hands-off grant. At its core, the opportunity is about making it easier, faster, and more cost-effective to run large, longitudinal, multi-site studies that rely on real-world clinical data and, where available, biospecimens collected through routine care across participating organizations.

The long-term objective of the overall HMO Collaboratory program is to strengthen national capacity and capability for conducting high-quality, large-scale research using primary clinical data and samples that already exist in health system environments. Instead of building one centralized mega-database, the vision emphasizes a distributed network of health care organizations, meaning data can remain within each organization while still being used for coordinated, multi-site research. This approach is intended to support studies that follow people over time, span multiple sites, and reflect the messy complexity of everyday clinical practice, which is often hard to capture in traditional clinical trials.

In this specific FOA, the Collaboratory Coordinating Center (CCC) is expected to play a backbone role. The CCC is responsible for developing and expanding the infrastructure needed to meet the collaboratory’s long-term goals, putting appropriate governance structures in place, and evaluating whether the resulting infrastructure is valuable and scalable for broader implementation. Practically, that points to work like creating common operating procedures, establishing policies for data access and use, coordinating cross-site collaboration, supporting study start-up and management, and ensuring that the network can function efficiently as a research platform rather than as a loose affiliation of independent projects.

A major component of the work described involves developing and improving research methodology through pilot projects. These pilots are a way to test and refine how the network will collect, standardize, and analyze information from electronic databases that include demographic, administrative, and clinical data, as well as information tied to biospecimens. The FOA emphasizes the use of electronic clinical databases as a core asset, which implies attention to data quality, harmonization across different systems, and methods for extracting comparable variables across organizations that may use different EHRs, coding practices, or workflows. The pilots are not just demonstrations; they are meant to surface real operational and scientific challenges and then drive practical solutions that can be reused across future studies.

The broader research payoff NIH is aiming for is the ability to generate stronger evidence for evaluating health care interventions using real-world populations and settings. The CCC-supported infrastructure is positioned to enable research that advances personalized medicine, prevention strategies, and population-based studies that include community participation. In other words, the network should help researchers learn what works, for whom, and under what circumstances, using routine-care data at scale rather than relying only on narrowly controlled trial environments.

A particularly important goal highlighted in the FOA is improving the nation’s ability to collect and curate both prospective and retrospective data that can inform research in groups that are often underrepresented in randomized controlled trials. The announcement explicitly mentions patients with multiple comorbidities, people at the extremes of age, rural populations, and minorities. This reflects a real limitation of many traditional trials, which frequently exclude complex patients or fail to recruit representative samples. By leveraging clinical data from health systems, the collaboratory model aims to capture more inclusive and clinically relevant populations, improving the generalizability of findings and supporting equity-oriented research.

Administratively, this opportunity was posted February 17, 2011, with an original and current closing date of May 27, 2011, and an archive date of June 27, 2011. The activity category is Health, and the CFDA number listed is 93.310 (Trans-NIH Research Support). Cost sharing or matching is not required. The eligible applicant list is broad and includes federal recognized tribal governments, other tribal organizations, for-profit entities (other than small businesses), small businesses, nonprofits (including both 501(c)(3) and non-501(c)(3)), public and private institutions of higher education, and a range of government entities (state, county, city/township, special districts), among others. The eligibility section also explicitly includes Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, Hispanic-serving institutions, HBCUs, TCCUs, regional organizations, and U.S. territories or possessions, reinforcing that NIH intended the applicant pool to be inclusive across organizational types and geographies.

Overall, the FOA is less about funding a single hypothesis-driven research study and more about funding the shared engine that makes many future studies feasible. The CCC is expected to build the operational, technical, and governance foundation for a distributed research network that can responsibly use electronic clinical data and biospecimen-related information to answer important real-world questions, test methods through pilot work, and demonstrate that the infrastructure is robust enough to scale beyond the initial effort.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Chemical Approaches to Target Validation for Drug Resistant Pathogens (R01)

Previous opportunity: Childhood Cancer Survivor Study (CCSS)(Limited Competition U24)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA RM 11 003

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA RM 11 003) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 11 003", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.